BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26678031)

  • 1. MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer.
    Wu X; Liu T; Fang O; Dong W; Zhang F; Leach L; Hu X; Luo Z
    Oncotarget; 2016 Jan; 7(3):2417-32. PubMed ID: 26678031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
    Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
    Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
    Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
    Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
    Bleau AM; Freire J; Pajares MJ; Zudaire I; Anton I; Nistal-Villán E; Redrado M; Zandueta CN; Garmendia I; Ajona D; Blanco D; Pio R; Lecanda F; Calvo A; Montuenga LM
    Int J Cancer; 2014 Dec; 135(11):2516-27. PubMed ID: 24473991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
    Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
    Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1.
    Qin Q; Wei F; Zhang J; Li B
    Oncol Rep; 2017 Feb; 37(2):823-830. PubMed ID: 28075475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.
    Liu C; Yang H; Xu Z; Li D; Zhou M; Xiao K; Shi Z; Zhu L; Yang L; Zhou R
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):431-41. PubMed ID: 25245053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
    Li X; Wan L; Geng J; Wu CL; Bai X
    J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway.
    Sun Y; Chen C; Zhang P; Xie H; Hou L; Hui Z; Xu Y; Du Q; Zhou X; Su B; Gao W
    Sci Rep; 2014 Oct; 4():6527. PubMed ID: 25284075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
    Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.
    Li J; Feng Q; Wei X; Yu Y
    Tumour Biol; 2016 Nov; 37(11):15221-15228. PubMed ID: 27683057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
    Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
    Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
    Xiao G; Gao X; Sun X; Yang C; Zhang B; Sun R; Huang G; Li X; Liu J; Du N; Liu D; Liang R; Ren H; Qin S
    Oncol Rep; 2017 Aug; 38(2):1190-1198. PubMed ID: 28656290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
    Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
    Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
    Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
    Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers.
    Liu Z; Mai C; Yang H; Zhen Y; Yu X; Hua S; Wu Q; Jiang Q; Zhang Y; Song X; Fang W
    J Cell Mol Med; 2014 Aug; 18(8):1667-79. PubMed ID: 24976536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo.
    Wang W; Dai LX; Zhang S; Yang Y; Yan N; Fan P; Dai L; Tian HW; Cheng L; Zhang XM; Li C; Zhang JF; Xu F; Shi G; Chen XL; Du T; Li YM; Wei YQ; Deng HX
    Neoplasma; 2013; 60(3):274-83. PubMed ID: 23373996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
    Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
    Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.